DAVITA INC (DVA) Stock Price, Forecast & Analysis
NYSE:DVA • US23918K1088
DVA Key Statistics, Chart & Performance
The current stock price of DVA is 150.79 USD. In the past month the price increased by 38.1%. In the past year, price decreased by -8.35%.
DVA Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to DVA. When comparing the yearly performance of all stocks, DVA turns out to be only a medium performer in the overall market: it outperformed 53.51% of all stocks.
DVA Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to DVA. DVA has an excellent profitability rating, but there are concerns on its financial health.
DVA Financial Highlights
Over the last trailing twelve months DVA reported a non-GAAP Earnings per Share(EPS) of 10.38. The EPS increased by 9.26% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.47% | ||
| ROA | 4.27% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
DVA Forecast & Estimates
17 analysts have analysed DVA and the average price target is 141.8 USD. This implies a price decrease of -5.96% is expected in the next year compared to the current price of 150.79.
For the next year, analysts expect an EPS growth of 27.42% and a revenue growth 3.33% for DVA
DVA Ownership
DVA Latest News, Press Relases and Analysis
DVA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 10.88 | 97.772B | ||
| CI | THE CIGNA GROUP | 9.38 | 77.65B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 97.94 | 24.095B | ||
| LH | LABCORP HOLDINGS INC | 15.75 | 24.032B | ||
| DGX | QUEST DIAGNOSTICS INC | 20.14 | 23.285B | ||
| GH | GUARDANT HEALTH INC | N/A | 13.861B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 27.87 | 7.225B | ||
| CHE | CHEMED CORP | 18.29 | 6.555B | ||
| OPCH | OPTION CARE HEALTH INC | 18.14 | 5.503B |
Related stock screener links
View all stocks in the Health Care Services Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About DVA
Company Profile
DaVita, Inc. engages in the provision of medical care services. The company is headquartered in Denver, Colorado. The firm is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. The company also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
Company Info
DAVITA INC
2000 16th St
Denver COLORADO 80202 US
CEO: Javier J. Rodriguez
Employees: 76000
Phone: 13105362668
DAVITA INC / DVA FAQ
What does DAVITA INC do?
DaVita, Inc. engages in the provision of medical care services. The company is headquartered in Denver, Colorado. The firm is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. The company also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
What is the stock price of DAVITA INC today?
The current stock price of DVA is 150.79 USD. The price increased by 4.52% in the last trading session.
What is the dividend status of DAVITA INC?
DVA does not pay a dividend.
What is the ChartMill technical and fundamental rating of DVA stock?
DVA has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Can you provide the PE ratio for DVA stock?
The PE ratio for DAVITA INC (DVA) is 14.53. This is based on the reported non-GAAP earnings per share of 10.38 and the current share price of 150.79 USD.
How many employees does DAVITA INC have?
DAVITA INC (DVA) currently has 76000 employees.
What is DAVITA INC worth?
DAVITA INC (DVA) has a market capitalization of 10.34B USD. This makes DVA a Large Cap stock.